Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2026-01-03 @ 10:00 AM
Study NCT ID:
NCT05066035
Status:
COMPLETED
Last Update Posted:
2021-10-04
First Post:
2021-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
Sponsor:
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Organization: